In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis
Yann-Érick Claessens(Centre National de la Recherche Scientifique), Michaëla Fontenay, Sylvie Gisselbrecht(Institut Cochin), Didier Bouscary(Centre National de la Recherche Scientifique), Jean‐Michel Dupont(Université Paris Cité), Catherine Lacombe(Centre National de la Recherche Scientifique), J Melle(Inserm), Françoise Picard(Délégation Paris 5), François Dreyfus(Université Paris-Sud), Patrick Mayeux(Université Paris Cité)
Cited by 144
Related Papers
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
|Leukemia|2011|464
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
|Haematologica|2009|316